Peptide Decoding
New?New to peptides?Start here →
Decoding

Palmitoyl Tetrapeptide-10_Dosage, benefits & legal status

Also known as {Palmitoyl-Lys}-Thr-Phe-Lys, palmitoyl tetrapeptide 10, N-Palmitoyl-Lys-Thr-Phe-Lys, Crystalide

Published November 17, 2026

A fatty-tailed cosmetic tetrapeptide with a labeling problem worth understanding.

Skin appearanceCosmetic tetrapeptide (topical, lipidated)Cosmetic
DoseSet by the finished product
FrequencyDaily, as directed by the product
RouteOn the skin (topical)
StatusCosmetic ingredient
CycledNot cycled

See how this dose compares across the library →

01

What is Palmitoyl Tetrapeptide-10?

Plain language first. The technical label stays, but it never stands alone.

Overview

A skin-conditioning peptide in prestige creams, whose evidence belongs to the mixture it comes in.

The technical version

Palmitoyl Tetrapeptide-10 is a lipidated cosmetic tetrapeptide marketed inside the Crystalide preparation for skin clarity and surface quality, with no controlled study of the isolated peptide.

What it's used for

A topical peptide used for skin clarity and texture, found in prestige anti-wrinkle creams as part of a multi-ingredient complex.

02

How does Palmitoyl Tetrapeptide-10 work?

What it does in the body, and where.

Palmitoyl Tetrapeptide-10 is lysine, threonine, phenylalanine, lysine, with a 16-carbon palmitic acid chain on the first lysine. The tail is the design: a bare four-residue peptide is too water-loving to cross the stratum corneum, and the fatty chain is what gets it in. Matrixyl, already on this site, is built the same way.

  1. 01
    The fatty tail carries it into the skin
    Palmitoylation is a standard trick in cosmetic peptide design, trading water solubility for the ability to pass through a lipid barrier. It is the same modification on Matrixyl and on Palmitoyl Tetrapeptide-7.
  2. 02
    The supplier's claim is a chaperone protein
    Croda markets the preparation as preserving skin transparency by inducing alpha-crystallin, a chaperone protein that keeps other proteins from misfolding and clumping, which is also what keeps the lens of the eye clear. The supplier further claims an epigenetic effect leading to what it calls harmonious skin maturation.
  3. 03
    None of that has been shown for the peptide by itself
    The claims are made for Crystalide, a seven-component preparation. No controlled study isolating this peptide was found. Reagent catalogs describe it raising corneodesmosin and filaggrin, and they say in the same sentence that it does this working together with other active ingredients.
  4. 04
    What the honest summary is
    A plausibly designed molecule with a real place in commerce and no published evidence of its own. That is the normal state for cosmetic peptides, and it is worth knowing before paying for it.
Anatomical illustration highlighting skin
WHERE THIS COMPOUND IS THOUGHT TO ACT:
Skin

03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Skin conditioning, which is the function chemical reference entries assign itnone
  • Skin clarity and surface quality, which is what the supplier markets the preparation fornone
  • Barrier support through corneodesmosin and filaggrin, a claim that reagent catalogs repeat and that is attributed to the peptide working with other activesnone

The published record

Research index

1

Papers about Palmitoyl Tetrapeptide-10 · this compound only

Searched: Palmitoyl Tetrapeptide-10, Crystalide, 887140-79-6, N-Palmitoyl-Lys-Thr-Phe-Lys.

Furthest stage reached: No clinical trial on record

Compare this against the whole library →

In animals0
In the lab0
Reviews0
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count. A preprint and its journal version count once.

Palmitoyl Tetrapeptide-10 vial rendering
Compound field notes

At a glance

Four things to know about Palmitoyl Tetrapeptide-10

01

Evidence

Cosmetic

02

Category

Skin and cosmetic

03

Common vial

Varies

04

Half-life

Not measured, and not the right question

04

How much, and do you cycle it?

The range, and whether you take breaks.

Set by the finished product, daily, as directed by the product. Not cycled Community practice

Used daily as part of a routine. Nothing about it suggests tolerance or a need for a break, and nothing has been studied that would show either way.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Not measured, and not the right questionNo figure

No half-life has been published for this peptide. It is applied to the skin in a finished cosmetic rather than dosed into the bloodstream, so a circulating half-life would not describe anything useful. The relevant question for a lipidated topical peptide is how much penetrates and how long it persists in the tissue, and that has not been published for this one.

You can compare this against the whole library to see where it sits.

06

How is it given?

Dosing context and source notes.
No draw available

Supplied as a ready-made solution, so there is nothing to mix.

No use level for the peptide itself was found in any document read here. What is published is a step removed: the 2026 prestige cream that made this ingredient visible declares 1 percent of the Crystalide preparation, and the preparation is a seven-component emulsion in which the peptide is the last ingredient named. So 1 percent Crystalide is not 1 percent peptide, and the peptide's share of it is not disclosed. On the cream's own full ingredient list the peptide appears dead last, after the preservative and the pH adjuster, which is where ingredients below about a tenth of a percent sit. A widely copied figure claiming a recommended level of 3 percent appears on a chemical aggregator with no source behind it and should not be used.

07

How do you store it?

Before mixing, and after.

Room temperature, out of light. Cap it tight after each use.

Palmitoyl Tetrapeptide-10 ships as a cream, gel, or serum. Keep it at room temperature away from sun and heat unless the label says otherwise. Refrigerating an emulsion can split the texture. Watch for color, smell, or separation changes and stop using it if any appear.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Who should avoid it

Check these before anything else.
  • A known allergy to this ingredient or to others in the same product
  • Broken, cracked, or actively irritated skin
  • Anyone who wants established safety data for the peptide itself, because none was found

Stop and get help

These are emergencies. Seek care.
  • A rash that spreads beyond where you applied it
  • Swelling of the face, lips, or eyelids, or any trouble breathing
  • Burning that does not settle after rinsing it off

Common effects

Expected, and usually mild.
  • No adverse effects are reported for the isolated peptide, and no published testing has looked for them. Irritation from a product containing it may come from anything else in the formula, which for this ingredient means at least six other components in the preparation alone.

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Palmitoyl Tetrapeptide-10 approved?

And where the numbers on this page come from.

Not as a medicine. Palmitoyl Tetrapeptide-10 is sold without a prescription as a cosmetic ingredient, which is a different thing from being approved as a drug.

What has happened recently

We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.

Guides for this compound

Sources

  • Croda Beauty Actives, Crystalide ingredient listing(2025)
    The supplier's ingredient listing, which is the document that settles what Crystalide actually is. The full INCI composition is water, caprylic/capric triglyceride, cetyl palmitate, sorbitan stearate, polysorbate 80, hydrogenated lecithin and Palmitoyl Tetrapeptide-10: seven components, the peptide last. The supplier claims the preparation preserves skin transparency by inducing the chaperone protein alpha-crystallin, describes a soft-polish effect revealing a uniform glow, and claims an epigenetic regulation leading to harmonious skin maturation and improved skin surface quality. No study, volunteer count or duration appears in the listing.
  • MedChemExpress, Palmitoyl tetrapeptide-10 product data sheet(2026)
    Reagent-supplier reference data, used here for the molecular identifiers, which agree with four other independent sources. CAS 887140-79-6, molecular formula C41H72N6O7, molecular weight 761.05, sequence palmitoyl-lysine then threonine, phenylalanine, lysine. The same sheet names its biological-activity reference as the 2022 open-label skincare-regimen study, which is the mis-citation described on this page.
  • Wenner and Ramberg, An Open-Label Study Assessing the Efficacy and Tolerability of a Skincare Regimen in Subjects of Different Ethnicities with Moderate-to-Severe Hyperpigmentation, Journal of Cosmetic Dermatology 21(6):2497-2507(2022)
    The study that reagent catalogs attach to this peptide, read at source so the mismatch can be stated precisely. It is an open-label trial of the Even Up Hyperpigmentation Regimen, three products from Colorescience, which sponsored the study. Conducted at a single eye and skin center in Washington state, received April 2021 and accepted August 2021. The reported outcomes are what subjects said about themselves by week 2: 76 percent reported lighter and less noticeable brown spots, 88 percent brighter and more luminous skin, 67 percent a more even tone, 85 percent a healthier look and feel. One of the two groups had 10 subjects. There is no control arm, no instrumental pigmentation measurement in the reported outcomes, and no mention of this peptide. It is not evidence about Palmitoyl Tetrapeptide-10. Its digital object identifier is 10.1111/jocd.14447. The abstract and the funding statement were read from a cached copy of the publisher's own PDF rather than from the publisher's site, which could not be opened here.
  • ChemicalBook CAS database entry, Palmitoyl Tetrapeptide-10(2026)
    Chemical reference entry used only to corroborate identity, which it does independently of the reagent sheet: the same CAS 887140-79-6, the same formula C41H72N6O7 and weight 761.05, the same InChIKey, the chemical name L-Lysine, N2-(1-oxohexadecyl)-L-lysyl-L-threonyl-L-phenylalanyl-, and the cosmetic ingredient function skin conditioning. The same page also carries an unsourced claim that the recommended level in skin care products is 3 percent, which is the figure this card tells you not to use.

Beyond these, 1 records are indexed for this compound. Browse the records